Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2007
10/18/2007WO2007092829A3 Stabilized compositions of proteins having a free thiol moiety
10/18/2007WO2007064345A3 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
10/18/2007WO2007059507A3 Compositions comprising lipoxygenase inhibitors and cyclodextrin
10/18/2007WO2007038658A3 Antibody-drug conjugates and methods of use
10/18/2007WO2007024574A3 Topical formulations of histone deacetylase inhibitors and methods of using the same
10/18/2007WO2007022924B1 Pharmaceutical compositions with melting point depressant agents and method of making same
10/18/2007WO2007022165B1 Factor xa inhibitor inclusion complex with cyclodextrin
10/18/2007US20070244323 Pharmaceutical Compositions Comprising Zd6474
10/18/2007US20070244299 Method of Stabilizing Proteins
10/18/2007US20070244203 Controlled-Release Composition for Topical Application and a Method of Delivering an Active Agent to a Substrate
10/18/2007US20070244049 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
10/18/2007US20070243588 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
10/18/2007US20070243311 Weight management system for obese animals
10/18/2007US20070243263 Antiviral Methods
10/18/2007US20070243234 Microscopic Tagging System for Security Identification
10/18/2007US20070243233 Bioactive-rich concentrates and nutritive and therapeutic products containing same
10/18/2007US20070243232 Method to treat and prevent asthma attacks using throat lozenges and orally-retained liquids containing magnesium
10/18/2007US20070243193 Compositions and methods for the diagnosis and treatment of tumor
10/18/2007US20070243185 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine.
10/18/2007US20070243175 Methods and compositions for regenerating tissue
10/18/2007US20070243174 Methods and compositions for directing stem cells to the liver
10/18/2007US20070243173 Methods and compositions for directing stem cells to the heart
10/18/2007US20070243139 A dimer of two polypeptides having specificity andreceptivity for different epitopes on a protein-tyrosinekinase receptor; linked by spacers; synergistic; contrast agents for radition imaging and therapy; biodrugs; hepatocyte growth factor receptor/cMET complex target; antitumor, -carcinogenic agents
10/18/2007CA2853611A1 High delivery rates for lipid based drug formulations, and methods of treatment thereof
10/18/2007CA2649199A1 Method of increasing the in vivo recovery of therapeutic polypeptides
10/18/2007CA2649025A1 Production method of liposome dispersion and production equipment thereof
10/18/2007CA2648395A1 Bifunctionalized polysaccharides
10/18/2007CA2647271A1 Binder for c-reactive protein
10/18/2007CA2646578A1 Novel formulations
10/18/2007CA2642757A1 Solid dispersion of poorly soluble drugs in graft copolymers
10/17/2007EP1845405A1 Liquid agent composition for contact lens
10/17/2007EP1845105A1 Modified exendins and uses thereof
10/17/2007EP1844798A1 Implantable putty material
10/17/2007EP1844794A1 Silicon implants comprising a radionucleotide and/or a cytotoxic drug and their use in cancer treatment
10/17/2007EP1844793A1 Cyclic AMP binding molecule as vehicle for gene therapy
10/17/2007EP1844789A1 Emulsified composition for dilution and cancer vaccine composition
10/17/2007EP1844786A1 Extracts of Curcuma longa and their cosmetic and dermatological uses
10/17/2007EP1844785A1 Phospholipid complexes of olive fruits or leaves extracts having improved bioavailability
10/17/2007EP1844773A1 Percutaneous absorption preparation
10/17/2007EP1844770A1 Tablets containing ornithine hydrochloride
10/17/2007EP1844764A2 Compound for use as a laxative
10/17/2007EP1844763A1 Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment
10/17/2007EP1844337A1 Binding compounds, immunogenic compounds and peptidomimetics
10/17/2007EP1844201A2 Aqueous gel formulations containing immune response modifiers
10/17/2007EP1843790A2 Insulin derivatives conjugated with structurally well defined branched polymers
10/17/2007EP1843783A2 Control of drug release by transient modification of local microenvironments
10/17/2007EP1843773A1 Method and composition for treatment of neoplasms
10/17/2007EP1843772A1 Intravenous formulations of pde-5 inhibitors
10/17/2007EP1843753A2 Compositions for freeze-drying proteins
10/17/2007EP1843749A1 Controlled release compositions for interferon based on pegt/pbt block copolymers
10/17/2007EP1646393A4 A stable clozapine suspension formulation
10/17/2007EP1546216B1 Methods of drug delivery using sulphated chitinous polymers
10/17/2007EP1482911B1 Water dispersible mixture comprising complex carbohydrates from aloe vera and polyvinylpyrrolidone
10/17/2007EP1427758B1 Compositions and methods of treating diabetes
10/17/2007EP1419191B1 Process for the preparation of activated polyethylene glycols
10/17/2007EP1417487B1 Epitope testing using hla
10/17/2007EP1416916B1 Chitin microparticles and their medical uses
10/17/2007EP1412424B1 Improvements in or relating to modified cellulose films
10/17/2007EP1412028B1 Tetrahydroindolone derivatives linked to arylpiperazines
10/17/2007EP1311289B1 Vaccines containing ribavirin
10/17/2007EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
10/17/2007EP1102758B1 Particle-forming compositions containing fused pyrrolocarbazoles
10/17/2007EP1093818B9 Powdery preparation for mucosal administration containing polymeric medicine
10/17/2007EP1075276B1 Adjuvant composition and methods for its use
10/17/2007EP1064346A4 High molecular weight polymer additive for coating and lubricating products
10/17/2007EP0993613B8 Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumours originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma
10/17/2007CN200960185Y Controllable degradable anti-cancer medicine sustained-release film support
10/17/2007CN101056658A Oral preparation having improved bioavailability
10/17/2007CN101056657A Antiviral composition
10/17/2007CN101056656A Reducing ER stress in the treatment of obesity and diabetes
10/17/2007CN101056650A Stable formulations of insulinoptropic peptides
10/17/2007CN101056636A Aqueous ophthalmic suspension of crystalline rebamipide
10/17/2007CN101056623A Stabilized freeze-dried formulation for cephalosporin derivatives
10/17/2007CN101056611A Gilsonite derived pharmaceutical delivery compositions and methods : cosmetic and nail applications
10/17/2007CN101054479A Effect pigments based on coated glass flakes
10/17/2007CN101053670A Silk fibroin and polymeric lactic acid compound film and its preparation method
10/17/2007CN101053662A Nonsteroidal antiinflammatories with nitric oxide donors and its preparation method
10/17/2007CN101053661A Tetramethylpyrazine derivatives modified silk fibroin protein fiber anti-coagulant material and its preparation method
10/17/2007CN101053660A Protein and peptide medicine carrier and its preparation method and application
10/17/2007CN101053659A Carried nitrosoureas medicine and alkaloids medicine for anti-cancer composition
10/17/2007CN101053657A External applied preparations for treating intractable skin ulcer
10/17/2007CN101053636A Medicinal composition for treating prostate and its preparation method and application
10/17/2007CN101053612A External applied traditional Chinese medicine vagina cleaning agent for curing gynecopathy and vagina cleaning ointment thereof
10/17/2007CN101053591A Man-brain imitation phosphatidylserine and composition and preparation method thereof
10/17/2007CN101053582A Method for applying complete puncturevine herb in preparing medicine for treating insulin resisting hyperglycemia and hypertension
10/17/2007CN101053568A Compound and its processing technology for compound sulfamonomethoxine sodium injection
10/17/2007CN101053562A Otilonium bromide capsule
10/17/2007CN101053556A Water soluble coenzyme Q10 hydroxyl-beta-cyclodextrin inclusion compound and its preparation method
10/17/2007CN101053555A Novel base materials of cataplasm and its preparing method
10/17/2007CN101053554A Ginkgolide B powder injection and its preparation method
10/17/2007CN101053553A Biodegradable fluorourcacil polyester medicine-carried nanospheres and its preparation method
10/17/2007CN101053552A O/W type emulsification preparation containing prednisolone valerate acetate
10/17/2007CN101053551A Carried nitrosoureas drug and alkylating agent for anti-cancer composition
10/17/2007CN101053550A Rhizoma Gastrodiae nasal gel preparation
10/17/2007CN100343393C Central airway administration for systemic delivery of therapeutics
10/17/2007CN100343305C Maleamic acid polymer derivatives and their bioconjugates
10/17/2007CN100343304C Hydrolytically stable maleimide-terminated polymers
10/17/2007CN100342914C Taxadol slow release nano-particle, its preparation method and application
10/17/2007CN100342913C Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification
10/17/2007CN100342912C Sustained release composition for oral administration of drugs
1 ... 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 ... 1712